According to Editas Medicine 's latest financial reports the company's current EPS (TTM) is -2,70 โฌ. In 2022 the company made an earnings per share (EPS) of -2,93 โฌ a decrease over its 2021 EPS that were of -2,60 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -2,81 โฌ | -4.01% |
2022 | -2,93 โฌ | 12.63% |
2021 | -2,60 โฌ | 43.22% |
2020 | -1,82 โฌ | -26.02% |
2019 | -2,45 โฌ | 15.45% |
2018 | -2,13 โฌ | -21.81% |
2017 | -2,72 โฌ | -1.65% |
2016 | -2,76 โฌ | -29.19% |
2015 | -3,90 โฌ |